{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:21:27Z","timestamp":1791177687400,"version":"4.1.0"},"reference-count":50,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T00:00:00Z","timestamp":1202774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Decis Making"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p>Background. A bioterrorism attack with an agent such as anthrax will require rapid deployment of medical and pharmaceutical supplies to exposed individuals. How should such a logistical system be organized? How much capacity should be built into each element of the bioterrorism response supply chain? Methods. The authors developed a compartmental model to evaluate the costs and benefits of various strategies for preattack stockpiling and postattack distribution and dispensing of medical and pharmaceutical supplies, as well as the benefits of rapid attack detection. Results. The authors show how the model can be used to address a broad range of logistical questions as well as related, nonlogistical questions (e.g., the cost-effectiveness of strategies to improve patient adherence to antibiotic regimens). They generate several key insights about appropriate strategies for local communities. First, stockpiling large local inventories of medical and pharmaceutical supplies is unlikely to be the most effective means of reducing mortality from an attack, given the availability of national and regional supplies. Instead, communities should create sufficient capacity for dispensing prophylactic antibiotics in the event of a large-scale bioterror attack. Second, improved surveillance systems can significantly reduce deaths from such an attack but only if the local community has sufficient antibiotic-dispensing capacity. Third, mortality from such an attack is significantly affected by the number of unexposed individuals seeking prophylaxis and treatment. Fourth, full adherence to treatment regimens is critical for reducing expected mortality. Conclusions. Effective preparation for response to potential bioterror attacks can avert deaths in the event of an attack. Models such as this one can help communities more effectively prepare for response to potential bioterror attacks.<\/jats:p>","DOI":"10.1177\/0272989x07312721","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T21:44:33Z","timestamp":1205876673000},"page":"332-350","source":"Crossref","is-referenced-by-count":55,"title":["Modeling the Logistics of Response to Anthrax Bioterrorism"],"prefix":"10.1177","volume":"28","author":[{"given":"Gregory S.","family":"Zaric","sequence":"first","affiliation":[{"name":"Ivey School of Business, University of Western Ontario, Canada,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena M.","family":"Bravata","sequence":"additional","affiliation":[{"name":"Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, Stanford-UCSF Evidence-Based Practice Center, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon-Erik","family":"Cleophas Holty","sequence":"additional","affiliation":[{"name":"Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, VA Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"McDonald","sequence":"additional","affiliation":[{"name":"Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, Stanford-UCSF Evidence-Based Practice Center, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[{"name":"Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, Stanford-UCSF Evidence-Based Practice Center, Stanford, California, VA Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Brandeau","sequence":"additional","affiliation":[{"name":"Department of Management Science and Engineering, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2008,2,12]]},"reference":[{"key":"atypb1","volume-title":"Severe Acute Respiratory Syndrome: Established Infectious Disease Control Measures Helped Contain Spread, but a Large-Scale Resurgence May Pose Challenges","author":"Kanof ME","year":"2003"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3549(04)50132-2"},{"key":"atypb3","volume-title":"Strategic National Stockpile","author":"Centers for Disease Control and Prevention.","year":"2003"},{"key":"atypb4","volume-title":"National Pharmaceutical Stockpile. 2003","author":"Centers for Disease Control and Prevention.","year":"2003"},{"key":"atypb5","volume-title":"Regionalization of Bioterrorism Preparedness and Response (Evidence Report\/Technology Assessment)","author":"Bravata DM","year":"2003"},{"key":"atypb6","volume-title":"Surge capacity: is it time to move beyond ``just-in-time''?","author":"US Medicine Institute for Health Studies.","year":"2002"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/58.3.233"},{"key":"atypb8","volume-title":"Department of Health and Human Services press release 1\/31\/02: HHS announces $1.1 billion in funding to states for bioterrorism preparedness","author":"US Department of Health and Human Services.","year":"2004"},{"key":"atypb9","volume-title":"Mass immunization campaigns: a ``how to'' guide based on experience during the February 2000 Capital Health Meningococcal Immunization Campaign","author":"Capitol Health.","year":"2000"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.3201\/eid0812.040421"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3549(04)50147-4"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1177\/027298902237709"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1287\/inte.1060.0229"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1287\/inte.1060.0257"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1287\/inte.1060.0241"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0636861100"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1080\/15031430410024363"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-4-200602210-00009"},{"key":"atypb19","volume-title":"Statistical Abstract of the United States","author":"US Bureau of the Census.","year":"2004"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.3201\/eid0802.01-0521"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020349"},{"key":"atypb22","volume-title":"Clinical pathway: anthrax inhalational exposure","author":"University of Minnesota Center for Infectious Disease Research and Policy.","year":"2002"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/2.2.233"},{"key":"atypb24","volume-title":"CDC Efforts to Assist State and Local Government Preparedness for Terrorist Attacks: Testimony before the Subcommittee on Government Efficiency, Financial Management, and Intergovernmental Relations, Committee on Government Reform Unites States House of Representatives","author":"Bice SD","year":"2002"},{"key":"atypb25","volume-title":"Receiving, Distributing, and Dispensing the National Pharmaceutical Stockpile: A Guide for Planners. Version 9","author":"Centers for Disease Control and Prevention.","year":"2002"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.21.2663-JWR1205-2-1"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.579"},{"key":"atypb28","volume-title":"Texas Society of Health-Systems Pharmacists Annual Meeting","author":"Benson B."},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00200-5"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1631983100"},{"key":"atypb31","volume-title":"Guidelines for acquisition of ventilators to meet demands for pandemic flu and mass casualty incidents","author":"American Association for Respiratory Care.","year":"2006"},{"key":"atypb32","author":"Hejik K.","year":"2003","journal-title":"Pharmacy Today"},{"key":"atypb33","volume-title":"Update on CDC's response to Hurricane Katrina","author":"Centers for Disease Control and Prevention.","year":"2005"},{"key":"atypb34","author":"Bradsher K.","year":"2001","journal-title":"The New York Times"},{"key":"atypb35","volume-title":"VA federal supply schedule service pharmaceuticals: current pharmaceutical products and pricing","author":"US Department of Veterans Affairs.","year":"2003"},{"key":"atypb36","author":"US Department of Veterans Affairs.","year":"2000","journal-title":"Veterans Administration Supply News"},{"key":"atypb37","volume-title":"Cost Containment of Medicaid HIV\/AIDS Drug Expenditures","author":"US Department of Health and Human Services.","year":"2001"},{"key":"atypb38","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"atypb39","volume-title":"Report 1 of the Council on Scientific Affairs (A-01): pharmaceutical expiration dates and AMA policy H-115.983 expiration dates and beyond-use dates of prescription drug products","author":"American Medical Association Council on Scientific Affairs.","year":"2003"},{"key":"atypb40","volume-title":"International information programs","author":"US Department of State.","year":"2001"},{"key":"atypb41","volume-title":"Salary tables and related information","author":"US Office of Personnel Management.","year":"2004"},{"key":"atypb42","volume-title":"Weill\/Cornell mass prophylaxis\/vaccination campaign staffing model","author":"Hupert N.","year":"2003"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1287\/inte.21.4.39"},{"key":"atypb44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1559-3584.2001.tb00034.x"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1002\/nav.3800320404"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2006.4.244"},{"key":"atypb47","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199912010-00006"},{"key":"atypb48","doi-asserted-by":"publisher","DOI":"10.3386\/w10179"},{"key":"atypb49","volume-title":"Scenario Planning Handbook: Developing Strategies in Uncertain Times","author":"Wilson I.","year":"2006"},{"key":"atypb50","volume-title":"Pediatric Anthrax: Implications for Bioterrorism Preparedness (Evidence Report\/ Technology Assessment)","author":"Bravata DM","year":"2006"}],"container-title":["Medical Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X07312721","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0272989X07312721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:53:29Z","timestamp":1777658009000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0272989X07312721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,12]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1177\/0272989X07312721"],"URL":"https:\/\/doi.org\/10.1177\/0272989x07312721","relation":{},"ISSN":["0272-989X","1552-681X"],"issn-type":[{"value":"0272-989X","type":"print"},{"value":"1552-681X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,12]]}}}